TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biognos AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
86
|
710 |
| Financial expenses |
0
|
1
|
0 |
| Earnings before taxes |
-818
|
-860
|
-203 |
| EBITDA |
-813
|
-846
|
-180 |
| Total assets |
404
|
390
|
377 |
| Current assets |
404
|
386
|
357 |
| Current liabilities |
280
|
256
|
313 |
| Equity capital |
124
|
134
|
64 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
30.7%
|
34.4%
|
17.0% |
| Turnover per employee |
0
|
86
|
710 |
| Profit as a percentage of turnover |
-1000%
|
-28.6% | |
| Return on assets (ROA) |
-202.5%
|
-220.3%
|
-53.8% |
| Current ratio |
144.3%
|
150.8%
|
114.1% |
| Return on equity (ROE) |
-659.7%
|
-641.8%
|
-317.2% |
| Change turnover |
-86
|
-567
|
7 |
| Change turnover % |
-100%
|
-87%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.